Skip to content

Deferred registration: HMR code: 25-008

Deferred registration: HMR code: 25-008 Full scientific title to be added on or before the deferral expiry date

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11686899
Enrollment
136
Registered
2026-07-15
Start date
2026-07-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers Other

Interventions

Sponsors

OnTrack Therapeutics Limited (a wholly owned subsidiary of Pangea Botanica Ltd [trading as Pangea Bio])
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Healthy human volunteer

Exclusion criteria

Exclusion criteria: This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Design outcomes

Primary

MeasureTime frame
[Outcome] measured using [measure] at [timepoint]. This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Secondary

MeasureTime frame
This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.

Countries

England, United Kingdom

Contacts

Public ContactThomas Pfeiffer
info@ontrack.health-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 10, 2026